List of SBIR/STTR awards granted to Sanguine Diagnostics And Therapeutics, Inc.

List of SBIR/STTR awards granted to Sanguine Diagnostics And Therapeutics, Inc.

List of SBIR/STTR awards granted to ALTEC INC

List of SBIR/STTR awards granted to INNOVATEK, INC.

List of SBIR/STTR awards granted to NANOHMICS INC

CEOs of data visualization companies

List of companies in Rajesh Mane's investment portfolio

where

SBIR/STTR Award Recipient

is

Sanguine Diagnostics And Therapeutics, Inc.

	Name	Description	SBIR/STTR Award Recipient	Government Agency	Government Branch	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
	‌ Sanguine Diagnostics And Therapeutics, Inc. SBIR Phase II Award, March 2018	A SBIR Phase II contract was awarded to Sanguine Diagnostics And Therapeutics, Inc. in March, 2018 for $1,315,426.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Sanguine Diagnostics And Therapeutics, Inc.		National Institutes of Health	SBIR	4R44DK117472-02	Phase II	1,315,426	March 1, 2018	sbir.gov/node/1568305
	‌ Sanguine Diagnostics And Therapeutics, Inc. SBIR Phase II Award, September 2018	A SBIR Phase II contract was awarded to Sanguine Diagnostics And Therapeutics, Inc. in September, 2018 for $1,300,714.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Sanguine Diagnostics And Therapeutics, Inc.		National Institutes of Health	SBIR	4R44CA224619-02	Phase II	1,300,714	September 1, 2018	sbir.gov/node/1573149
	‌ Sanguine Diagnostics And Therapeutics, Inc. SBIR Phase I Award, March 2018	A SBIR Phase I contract was awarded to Sanguine Diagnostics And Therapeutics, Inc. in March, 2018 for $196,647.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Sanguine Diagnostics And Therapeutics, Inc.		National Institutes of Health	SBIR	1R44CA224619-01A1	Phase I	196,647	March 1, 2018	sbir.gov/node/1567459
	‌ Sanguine Diagnostics And Therapeutics, Inc. SBIR Phase I Award, March 2019	A SBIR Phase I contract was awarded to Sanguine Diagnostics And Therapeutics, Inc. in March, 2019 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Sanguine Diagnostics And Therapeutics, Inc.		National Institutes of Health	SBIR	1R43CA235984-01	Phase I	225,000	March 1, 2019	sbir.gov/node/1679341
	‌ Sanguine Diagnostics And Therapeutics, Inc. STTR Phase I Award, September 2016	A STTR Phase I contract was awarded to Sanguine Diagnostics And Therapeutics, Inc. in September, 2016 for $300,000.0 USD from the U.S. Department of Health & Human Services.	Sanguine Diagnostics And Therapeutics, Inc.			STTR	1R41CA213718-01	Phase I	300,000	September 13, 2016	sbir.gov/node/1195441
	‌ Sanguine Diagnostics And Therapeutics, Inc. SBIR Phase I Award, September 2017	A SBIR Phase I contract was awarded to Sanguine Diagnostics And Therapeutics, Inc. in September, 2017 for $199,020.0 USD from the U.S. Department of Health & Human Services.	Sanguine Diagnostics And Therapeutics, Inc.			SBIR	4R44DK117472-02	Phase I	199,020	September 12, 2017	sbir.gov/node/1324405
	‌ Sanguine Diagnostics And Therapeutics, Inc. STTR Phase I Award,	A STTR Phase I contract was awarded to Sanguine Diagnostics And Therapeutics, Inc. for $225,000.0 USD from the U.S. Department of Health & Human Services.	Sanguine Diagnostics And Therapeutics, Inc.			STTR	1R41CA177288-01A1	Phase I	225,000		sbir.gov/node/707170

7 results

0 selected

7 results

0 selected